logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. SunAct Cancer Institute

Verified
+918655313412
contact@sunactcancer.com
Source: Site record.
http://www.sunactcancer.com

Basic Information

Site Overview

Source: Human-provided.

SunAct – Advanced Cancer Therapies is a pioneering oncology centre in India focused on delivering next-generation, personalized cancer care by combining conventional oncology with cutting-edge cellular and gene-based therapies. With flagship facilities in Thane (Mumbai) and Khar (Mumbai) and additional centres in Nashik and Kerala, SunAct provides a wide spectrum of services including CAR T-cell therapy, TCR therapy, tumor-infiltrating lymphocyte (TIL) therapies, gene and CRISPR-based treatments, bone marrow and stem cell transplantation, immunotherapy, targeted therapy, and chemotherapy, supported by expert multidisciplinary oncology teams. The institute emphasises advanced cellular therapies and precision medicine for both haematologic and solid tumours, striving to make such innovative treatments more accessible and affordable within India while engaging in clinical research, trials, and global collaborations. SunAct’s facilities feature state-of-the-art infrastructure,…

Business Status

Source: Google. OPEN

Business Category

Source: Google. Oncologist

Business Subcategory

Source: Google. Oncologist
Source: Google. Cancer treatment center
Source: Google. Hospital
Source: Google. Pediatric oncologist
Source: Google. Surgical oncologist
Source: Trial-derived.
5Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
5Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
7Unique Conditions
Source: Trial-derived.
5Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Adenoid Cystic Carcinoma Metastatic (1)Source: Trial-derived. Adenoid Cystic Carcinoma of the Head and Neck (1)Source: Trial-derived. Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) (1)Source: Trial-derived. Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer (1)Source: Trial-derived. NSCLC Patients With EGFR Activating Mutation (1)Source: Trial-derived. Relapsed Advanced Lymphomas (1)Source: Trial-derived. Relapsed Malignant Solid Neoplasm (1)

Sponsors

Source: Trial-derived. Aurigene Discovery Technologies Limited (2)Source: Trial-derived. Hoffmann-La Roche (1)Source: Trial-derived. Immutep S.A.S. (1)Source: Trial-derived. Jubilant Therapeutics India Limited (1)Source: Trial-derived. Merck Sharp & Dohme LLC (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 8

Principal investigators

Source: Human-provided. 9

Study coordinators

Source: Human-provided. 16

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Amenities

Amenities Available

Source: Google. Restroom
Source: Google. Gender-neutral restroom
Source: Google. Nursing room

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Tumour response imaging